Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome.
Sasaki
Nana
N
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
Kuroda
Junya
J
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan. junkuro@koto.kpu-m.ac.jp.
Kawata
Eri
E
Division of Hematology, Kyoto Second Red Cross Hospital, 355-5, Haruobi-cho, Kamigyo-ku, Kyoto, 602-8026, Japan.
Akaogi
Teruaki
T
Division of Hematology, Kyoto Second Red Cross Hospital, 355-5, Haruobi-cho, Kamigyo-ku, Kyoto, 602-8026, Japan.
Kiyota
Miki
M
Division of Hematology, Kyoto Second Red Cross Hospital, 355-5, Haruobi-cho, Kamigyo-ku, Kyoto, 602-8026, Japan.
Kobayashi
Yutaka
Y
Division of Hematology, Kyoto Second Red Cross Hospital, 355-5, Haruobi-cho, Kamigyo-ku, Kyoto, 602-8026, Japan.
Taniwaki
Masafumi
M
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001772:Blood Cell Count; D001853:Bone Marrow / Q000473:pathology; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000150:complications* / Q000473:pathology / Q000628:therapy*; D010951:Plasma Exchange; D011239:Prednisolone / Q000008:administration & dosage; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000473:pathology / Q000628:therapy*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone